VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
FATE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
FATEFate Therapeutics, Inc.
$2.32$270M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFATEPrice History

FATE logoFate Therapeutics, Inc. (FATE) Stock Price History

Historical prices from 2013 to 2026

$2.32+0.02  (+0.87%)close Oct 2
Returns
1M
-5.3%
3M
-20.5%
YTD
+135.2%
1Y
+91.7%
3Y
+6.5%
5Y
-47.2%
ATH$121.16Jan 2021-98.1%
ATL$0.66Apr 2025pre-split
Avg Vol (50D)1.7M/ day
52-Week Range$0.95 — $3.23
LowCurrent: $2.32High

Loading 10-year price history...

FATE Historical Performance

1 YearTotal Return
+91.7%
Price: +91.7%
3 YearsTotal Return
+20.8%
CAGR: +6.5%
Price: +20.8%
5 YearsTotal Return
-95.9%
CAGR: -47.2%
Price: -95.9%
YTD
+135.2%

FATE Annual Returns

Year-by-year price performance · 2013–2026

Best+367.0%2020
Worst-83.3%2022
Up years5/14
2013-5.1%
2014-20.9%
2015-34.4%
2016-23.7%
2017+127.1%
2018+103.7%
2019+44.6%
2020+367.0%
2021-34.8%
2022-83.3%
2023-63.2%
2024-55.3%
2025-45.3%
2026+147.5%
2013 annual price return
-5.1%
2014 annual price return
-20.9%
2015 annual price return
-34.4%
2016 annual price return
-23.7%
2017 annual price return
+127.1%
2018 annual price return
+103.7%
2019 annual price return
+44.6%
2020 annual price return
+367.0%
2021 annual price return
-34.8%
2022 annual price return
-83.3%
2023 annual price return
-63.2%
2024 annual price return
-55.3%
2025 annual price return
-45.3%
2026 annual price return
+147.5%
LessMore
Alpha vs S&P 500
1Y+76.7%
3Y-15.5%
5Y-60.2%

Price returns only.

Download Historical Data

3,271 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

FATE Stock Price Trajectory (2013–2026)

As of October 3, 2026, Fate Therapeutics, Inc. (FATE) trades at $2.32, representing a +91.7% return over the past year. The stock has delivered a -95.9% total return over five years (-47.2% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $121.16 on January 14, 2021. From this peak, FATE has corrected -98.1%, currently trading 25% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers CRSP (-23.9% 1Y), NTLA (-40.0% 1Y), and BEAM (-4.3% 1Y), FATE has outperformed the peer group average. Compare FATE vs CRSP →

FATE Historical Price Data · from 2013

Rows 1–50 of 3,271
Date Open High Low Close Volume Change %
2026-10-022.342.352.272.32644K+0.87%
2026-10-012.372.382.292.30811K-2.95%
2026-09-302.402.502.352.371.08M-0.42%
2026-09-292.372.402.292.381.25M0.00%
2026-09-282.302.422.272.381.14M+1.28%
2026-09-252.302.462.272.353.39M+0.86%
2026-09-242.402.432.272.331.18M-4.12%
2026-09-232.572.582.432.43903K-5.81%
2026-09-222.522.632.522.581.66M+1.98%
2026-09-212.462.582.462.531.27M0.00%
2026-09-182.562.602.502.534.13M+0.40%
2026-09-172.502.692.462.525.13M+3.28%
2026-09-162.352.462.352.441.27M+3.83%
2026-09-152.332.392.272.35767K+0.43%
2026-09-142.302.402.282.34646K+1.30%
2026-09-112.362.392.302.31742K-0.86%
2026-09-102.382.452.282.33751K-4.51%
2026-09-092.462.522.422.44553K-2.40%
2026-09-082.402.552.402.501.92M+0.81%
2026-09-042.382.492.382.48610K+2.48%
2026-09-032.472.502.402.42715K-1.22%
2026-09-022.432.502.382.451.15M+0.82%
2026-09-012.382.482.332.431.04M+1.67%
2026-08-312.402.442.372.39548K-1.65%
2026-08-282.442.532.412.43709K-4.33%
2026-08-272.562.592.502.541.56M-1.17%
2026-08-262.542.602.502.571.05M+0.78%
2026-08-252.462.622.462.552.43M+4.51%
2026-08-242.342.452.232.441.31M+4.72%
2026-08-212.462.512.322.331.70M-4.90%
2026-08-202.652.652.442.451.57M-7.55%
2026-08-192.612.702.592.651.22M+3.52%
2026-08-182.592.632.532.56943K-2.29%
2026-08-172.572.702.512.623.18M+1.95%
2026-08-142.582.602.482.572.00M+1.98%
2026-08-132.832.852.512.522.37M-7.35%
2026-08-122.752.812.692.721.23M-0.73%
2026-08-112.792.822.692.741.28M-0.72%
2026-08-102.852.852.742.761.95M-1.43%
2026-08-072.532.882.482.804.02M+12.45%
2026-08-062.642.642.462.492.23M-4.23%
2026-08-052.622.682.562.603.39M+1.17%
2026-08-042.532.692.412.576.44M+2.80%
2026-08-032.432.552.372.501.25M+2.04%
2026-07-312.512.562.392.451.46M-2.39%
2026-07-302.362.552.352.511.70M+6.36%
2026-07-292.332.432.262.361.14M+1.72%
2026-07-282.422.422.252.321.85M-4.53%
2026-07-272.492.522.392.43564K+0.83%
2026-07-242.522.552.402.411.04M-4.37%
…
Consensus & Technical Research Suite
Open FATE Terminal

FATE Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

FATE — Frequently Asked Questions

Quick answers to the most common questions about buying FATE stock.

How has FATE stock performed recently?

FATE returned +91.7% over the past year, beating its 5-year annualized CAGR of -47.2%. The stock trades above its 200-day moving average, confirming the uptrend.

What is FATE's all-time high price?

Fate Therapeutics, Inc. reached $121.16 on 2021-01-14. The 52-week high is $3.23. Current 1-year return of +91.7% places the stock closer to historical peaks.

Where can I download FATE historical price data?

This page provides FATE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2013-2026, downloadable in CSV format.

469 data points · sampled from 3,271